These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Gingival hyperplasia of drug origin. A review of the literature]. Roehrich N; Cimasoni G Schweiz Monatsschr Zahnmed; 1994; 104(12):1471-81. PubMed ID: 7824897 [TBL] [Abstract][Full Text] [Related]
25. [Biochemical study of diphenylhydantoin gingival hyperplasia--effect of diphenylhydantoin on gingival C14-1,4-succinate metabolism]. Deguchi S Nihon Shishubyo Gakkai Kaishi; 1986 Mar; 28(1):1-16. PubMed ID: 3459761 [No Abstract] [Full Text] [Related]
26. [Histomorphometric study of the effect of sodium dilantin on the gingival tissues of rats]. do Nascimento A; Barreto RC; Bozzo L J Biol Buccale; 1983 Jun; 11(2):119-23. PubMed ID: 6576999 [TBL] [Abstract][Full Text] [Related]
28. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development. Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082 [No Abstract] [Full Text] [Related]
29. Dilantin and its effects on the gingival tissues. KLASKIN G Contact Point; 1948 Apr; 26(7):211-5. PubMed ID: 18910782 [No Abstract] [Full Text] [Related]
30. Gingival overgrowth in partially edentulous ridges in an elderly female patient with epilepsy: a case report. Dhingra K; Prakash S Gerodontology; 2012 Jun; 29(2):e1201-6. PubMed ID: 22612838 [TBL] [Abstract][Full Text] [Related]
31. Dilantin gingival hyperplasia; report of a case. BLAKE H; BLAKE FS Oral Surg Oral Med Oral Pathol; 1953 Jul; 6(7):818-21. PubMed ID: 13073184 [No Abstract] [Full Text] [Related]
32. [Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison]. Silvestri E; Veraldi S; Piferi M; Sala F; Bencini L; Marini D Minerva Stomatol; 1988 Mar; 37(3):189-92. PubMed ID: 3166093 [No Abstract] [Full Text] [Related]
33. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin]. Mattioli A; Mauro S; Menetti L; Orlando S Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558 [TBL] [Abstract][Full Text] [Related]
34. A clinicopathological review. Diphenylhydantoin gingival hyperplasia: 2. Aetiology, pathogenesis, differential diagnosis and treatment. Angelopoulos AP Dent J; 1975 May; 41(5):275-7, 283. PubMed ID: 1055114 [No Abstract] [Full Text] [Related]
35. Effects of dilantin on monocytic growth factors. Offenbacher S J Periodontol; 1993 Mar; 64(3):237-8. PubMed ID: 8463947 [No Abstract] [Full Text] [Related]
36. Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Hassell TM; Page RC; Narayanan AS; Cooper CG Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2909-12. PubMed ID: 1066702 [TBL] [Abstract][Full Text] [Related]
37. [Experimental study of tissue culture on the etiology of 5,5-diphenylhydantoin gingival hyperplasia]. Yoshizumi T Shikwa Gakuho; 1971 Jan; 71(1):183-207. PubMed ID: 5278118 [No Abstract] [Full Text] [Related]
38. [Experimental study of the effect of the administration of diphenyl hydantoin and estrogens. II. Histopathological aspects of gingival changes in rats treated with diphenylhydantoin]. Hernandez Vallejo G; Bascones A; Alonso A; Nieto-Camacho CM; Esteban M; Mosso MA; Lucas Tomas M Rev Esp Estomatol; 1984; 32(4):223-32. PubMed ID: 6599333 [No Abstract] [Full Text] [Related]
39. The relationship of 5,5-diphenylhydantoin metabolism to the species-specific induction of gingival hyperplasia in the rat. Conard GJ; Haavik CO; Finger KF Arch Oral Biol; 1972 Feb; 17(2):311-21. PubMed ID: 4502048 [No Abstract] [Full Text] [Related]